Additionally, Zepbounds dual-action mechanism, targeting both GLP-1 and GIP receptors, is believed to enhance its effectiveness in reducing appetite and improving insulin sensitivity
The standard initiation protocol involves starting at 0.25 mg once weekly for four weeks (a non-therapeutic dose intended to improve gastrointestinal tolerability), then increasing to 0.5 mg weekly
A: The first step is to get a specialized hormonal panel done
Originally developed and approved for the management of type 2 diabetes, GLP-1 (glucagon-like peptide-1) receptor agonists have revolutionized the field of obesity medicine
Theres a lingering belief that if you just try hard enough, you should be able to maintain weight loss through diet and exercise alone
Seki H, Ideno S, Shiga T et al (2023) Sodium-glucose cotransporter 2 inhibitor-associated perioperative ketoacidosis: a systematic review of case reports